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Mitochondrial biogenesisGrowth factor activates mitogen-activated protein kinase kinases to promote cell growth. Mitochondrial
biogenesis is an integral part of cell growth. How growth factor regulates mitochondrial biogenesis is not fully
understood. In this study, we found that mitochondrial mass was speciﬁcally reduced upon serum starvation
and induced upon re-feeding with serum. Using mitogen-activated protein kinase kinases inhibitor U0126,
we found that the mRNA expression levels of ATP synthase, cytochrome-C, mitochondrial transcription factor
A, and mitofusin 2 were reduced. Since the transcriptional levels of these genes are under the control of
peroxisome proliferator-activated receptor γ coactivator-1α and -1β (PGC-1α and PGC-1β), we examined
and found that only themRNA and protein levels of PGC-1βwere suppressed. Importantly, over-expression of
PGC-1β partially reversed the reduction of mitochondrial mass upon U0126 treatment. Thus, we conclude
that mitogen-activated protein kinase kinases direct mitochondrial biogenesis through selectively inducing
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Growth factor activation of receptor tyrosine kinase,whicheventually
activates mitogen-activated protein kinase kinases (MEK1/2) and their
down-stream targets extracellular signal-regulated kinases (ERK1/2),
plays a central role in the regulation of cell growth and proliferation [1].
Mutations or ampliﬁcations of these signaling molecules can contribute
to the development of a broad spectrum of human cancers [2].Suppression of ERK activation by speciﬁc inhibitors, dominant-negative
forms of ERK, as well as ERK antisense nucleotides have been shown to
inhibit cell proliferation and induce apoptosis; furthermore, MEK
inhibitors signiﬁcantly altered the abilities of these cells to proliferate in
response to growth factor stimulation [2].
The roles of mitochondrial biogenesis and function in cell growth
and proliferation are actively being investigated. In order to promote
cell growth and division, the MEK–ERK cascade needs to coordinately
regulate protein, nucleic acid, and lipid biosynthesis for genome and
organelle duplications. All of these processes consume high levels of
energy; thus, mitochondrial biogenesis and energy metabolism must
also be highly coordinated by the MEK–ERK cascade. Recent studies
have shown that modulating ERK1/2 activities alters mitochondrial
function [3,4]. However, how MEK–ERK cascade governs mitochon-
drial biogenesis remains undeﬁned.
Estrogen-related receptors α and γ (ERRα and ERRγ) together
with their coactivators peroxisome proliferator-activated receptor γ
coactivator-1α and -1β (PGC-1α and PGC-1β) are key regulators of
mitochondria biogenesis and function [5,6]. These transcriptional
regulators bind to response elements located on the promoters
of their target genes such as ATP synthase (ATP5b), cytochrome-C
(cyt-C), mitochondrial transcription factor A (Tfam), and mitofusin 2
(Mfn2) to guide the expressions of these mitochondrial enzymes and
regulators [7]. In this study, we investigated whether ERRα, ERRγ,
PGC-1α, and PGC-1β participate in communicating the signal from
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that the mRNA expression level of PGC-1βwas speciﬁcally induced by
the MEK–ERK cascade.2. Material and methods
2.1. Cell culture
Human non-small cell lung cancer (NSCLC) A549 cells were
purchased from American Type Culture Collection (ATCC) and cultured
in RIPM1640 medium (Gibco) supplemented with 10% fetal bovine
serum (FBS) (Hyclone) at 37 °C in 5% CO2.2.2. Confocal laser scanning microscopy of mitochondrial mass
A549 cells were seeded onto coverslip in 6-well plates and
cultured overnight, after starvation or re-feeding treatment, cells
were incubated in pre-warmed serum free medium with 400 nM
Mitotracker Green FM and 10 μg/ml 4′,6-diamidino-2-phenylindole
(DAPI) for 20 min in the dark. After staining, cells were washed four
times with cold phosphate-buffered saline (PBS) and mounted on
glass slides. Imageswere subsequently takenwith a Leica SP2 confocal
microscope (Leica Microsystems, Mannheim, Germany).2.3. Mitochondrial mass measurement
Mitotracker green (Invitrogen) was added and quantiﬁed as
described [8]. Brieﬂy, cells were incubated in serum free medium
(pre-warmed to 37 °C) with 150 nMMitotracker Green FM for 20 min
in the dark. After staining, cells were washed twice with cold
phosphate-buffered saline (PBS) and suspended in 200 μl PBS.
Subsequently, cells were analyzed on a ﬂow cytometer (FAC-SCalibur,
BD Biosciences) with excitation at 490 nm and emission at 516 nm.
Data were processed by using the CellQuest program (BD Bio-
sciences). Assays done in triplicate were repeated at least three times.2.4. Cellular ATP level measurement
Total cellular ATP level was measured by ATPlite-glo (PerkinEl-
mer) following the manufacture's protocol using VERITASTM Micro-
plate luminometer (Turner Biosystems) as described [9].2.5. Quantitative real-time PCR
Total RNA extraction, ﬁrst-strand cDNA generation, and quantita-
tive real-time PCR analysis were performed as described [10]. Relative
gene expression was normalized to 18 S rRNA levels. Primer
sequences and real-time PCR conditions are listed in Table S1 of the
supplementary data.2.6. Western blot analysis
Cell extracts weremade in RIPA buffer (50 mMTris pH7.5, 150 mM
NaCl, 10 mM EDTA, 1% NP-40, 0.1% SDS, 1 mM PMSF, 10 μg/ml
Aprotinin) and whole cell extracts (50–75 μg of protein) were treated
with SDS sample buffer, boiled for 5 min, and subjected to SDS–PAGE
and Western analysis by ECL Western Blotting System (Amersham
Pharmacia, UK). Membranes were incubated with rabbit anti-ERRα,
-ERRγ, -PGC-1α, and -PGC-1β antibodies [11,12], or mouse anti-β-
actin antibody (Boster) followed by horseradish peroxidase-conju-
gated secondary antibody (Amersham) and developed with ECL
reagent (Amersham).2.7. Plasmids and transient transfection
A pGL3-PGC-1β-promoter reporter plasmid was cloned by PCR
ampliﬁcation of its 2 kb genomic region upstream of the transcrip-
tional start site into a pGL3-luciferase vector (Promega). Transient
transfections were performed using Lipofectamine 2000 (Invitrogen)
following the manufacturer's instructions. For luciferase reporter
assays, cells at 85–95% conﬂuency in 96-well plates were cotrans-
fected with reporter plasmids (25 ng/well) and Renilla luciferase
(3 ng/well) as an internal control for transfection efﬁciency. Six hours
after transfection, cells were starved in different amount of FBS or
treated with U0126 for 24 h. Luciferase activity was measured as
described [13,14].2.8. Over-expression by transient transfection
A pcDNA3.1-PGC-1β-expression plasmid was cloned by PCR
ampliﬁcation, MEK1 and MEK2 plasmids were gifts from Dr. Sylvain
Meloche [15]. Cells were over-expressedwith pcDNA3.1 or expression
plasmids using Lipofectamine 2000 (Invitrogen).2.9. Statistical analysis
Data are presented as mean±SE and analyzed by a variance test
(ANOVA). Asterisks indicate signiﬁcant differences: *Pb0.05, **Pb0.01.3. Results
3.1. Growth factor signaling and mitochondrial biogenesis
In order to address the importance of mitochondrial biogenesis in
mediating growth factor stimulated cell proliferation, we ﬁrst moni-
tored the changes in mitochondrial mass in human non-small cell lung
cancer A549 cells that were serum-starved and then re-fed with serum.
Using Mitotracker Green, a ﬂuorescence dye that binds to mitochon-
drion independent of its potential, we found by confocal microscopy
that the amount of stained mitochondria reduced upon serum
starvation but rebound partially upon serum re-fed (Fig. 1A). In order
to quantify the changes, we starved cells in different amounts of serum
to induce cell cycle arrest (supplemental data Fig. S1) followed by
ﬂuorescence-assisted cell sorting analysis (supplemental data Fig. S2).
We found that serum starvation quantitatively reduced mitochondrial
mass and the decrease was negatively correlated to the amount of
serum supplemented (Fig. 1B). We then asked how quickly mitochon-
drial biogenesis would increase upon growth factor stimulation in
starved cells re-fed with 10% FBS. We found that mitochondrial mass
increased gradually over time as cells were released from cell cycle
arrest (Fig. 1C). Similar observations were obtained using another lung
cancer cell line 95D and a colon cancer cell line HCT-116 (supplemental
data Fig. S3).
Besides quantifying mitochondrial mass by ﬂuorescence dye
staining, we also measured the mRNA expression levels of several
nuclear-encoded mitochondrial regulatory factors such as Mfn2 and
Tfam aswell as respiratory chain enzymatic components such as cyt-C
and ATP5b. Correspondingly, the mRNA expression levels of these
genes, which serve as markers to more globally reﬂect the changes in
mitochondrial biogenesis and function, were all reduced by serum
starvation and stimulated by re-feeding with serum (Fig. 1D).
Additionally, we checked the mRNA expression levels of several
mitochondrial DNA-encoded respiratory chain enzymatic compo-
nents such as cytochrome b (MT-CYB), cytochrome c oxidase subunit I
(MT-COI), and ATP synthase 6 (MT-ATP6) and found similar modes of
regulation (Fig. 1E).
Fig. 1. Growth factor signaling and mitochondrial biogenesis. (A) Separate and merged confocal images of A549 cells after staining with Mitotracker Green and 4′,6-diamidino-2-
phenylindole (DAPI) under 10% FBS (Normal), 0.1% FBS (Starvation), and 0.1% FBS overnight followed by 18 h in 10% FBS (Re-fed). (B–C)Mitochondrial mass wasmeasured as in Ref.
[9]. (B) Cells were grown in different amounts of serum indicated for 24 h. The relative amount in 10% FBS was set as 100%. (C) Cells were ﬁrst starved in 0.1% FBS overnight before re-
feeding with 10% FBS for different amounts of time indicated. The relative amount without re-feedingwas set as 100%. (D–E)mRNA expression levels of ATP5b, cyt-C, Mfn2, and Tfam
(D), mitochondrial DNA-encoded respiratory chain enzymatic components MT-CYB, MT-COI, and MT-ATP6 (E) mRNA expression levels were measured under 10% FBS (Normal),
0.1% FBS (Starvation), and 0.1% FBS overnight followed by 18 h in 10% FBS (Re-fed). Relative gene expression was normalized to 18 S rRNA and the relative level under normal
condition was set at 1. Data are presented as mean±SE and analyzed by a variance test (ANOVA). Asterisks indicate signiﬁcant differences: *Pb0.05, **Pb0.01.
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Fig. 2. Suppressing MEK1/2 activities reduces mitochondrial mass and function. (A) Mitochondrial mass levels were measured as in Fig. 1 after cells were treated with different
amounts of U0126 for 24 h. (B) Mfn2 and TfammRNA expression levels of cells in (A) were measured as in Fig. 1. (C) Cellular ATP levels of cells in (A) were measured as in “Materials
and methods.” (D) ATP5b and cyt-C mRNA expression levels of cells in (A) were measured as in Fig. 1. Statistical analysis was performed as in Fig. 1.
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function
To explore if inhibiting MEK1/2 alters mitochondrial mass, we
treated normally growing A549 cells dose-dependently with a MEK1/
2 inhibitor U0126 to induce cell cycle arrest in the G1 phase
(supplemental data Fig. S4). Concordantly, U0126 dose-dependently
reduced mitochondrial mass (Fig. 2A) and suppressed the mRNA
expression levels of Tfam and Mfn2 (Fig. 2B). In addition, we
investigated if ATP production was reduced due to the loss of
mitochondrial mass. We indeed found that U0126 dose-dependently
lowered the total cellular ATP level (Fig. 2C) and suppressed the
mRNA expression levels of ATP5b and cyt-C (Fig. 2D) as well as MT-
CYB, MT-COI, and MT-ATP6 expressions (supplemental data Fig. S5).
Although less effective compared to U0126, we also found that
another inhibitor PD98059 which only inhibits MEK1 modestly
reduced mitochondrial mass and partially suppressed the expression
of these genes (supplemental data Fig. S6).Fig. 3. Suppressing MEK1/2 activities selectively reduces PGC-1β expression. (A) mRNA expr
of U0126 for 24 h were measured. The relative expression levels of these genes under DMS
performed for ERRα, ERRγ, PGC-1α, and PGC-1β with β-actin as a control. Statistical analy3.3. Suppressing MEK1/2 activities selectively reduces PGC-1β expression
Since the transcriptional expression levels of ATP5b, cyt-C, Tfam,
and Mfn2 are in part controlled by ERRα, ERRγ, PGC-1α, and PGC-1β,
we next examined if the mRNA and protein levels of these factors
were altered by suppressing MEK1/2 activities. We found that U0126
did not signiﬁcantly alter the mRNA or the protein levels of ERRα,
ERRγ, and PGC-1α (Fig. 3A and B). On the other hand, U0126
selectively and dose-dependently suppressed the mRNA and protein
levels of PGC-1β (Fig. 3A and B).
Since suppressing MEK1/2 activities selectively reduces PGC-1β
expression,we then checked if serum starvation and re-fed treatments
altered PGC-1β expression. We found that PGC-1β mRNA level was
reduced by serum starvation and elevated upon re-feedingwith serum
(Fig. 4A). We then cloned the 2 kb promoter region of PGC-1β
upstream of its transcriptional start site into a luciferase reporter [8].
Using this PGC-1β-promoter-luciferase reporter, we were able to
recapture the responses to serum starvation (Fig. 4B) and U0126ession levels of ERRα, ERRγ, PGC-1α, and PGC-1β in cells treated with different amounts
O treatment as a control were set as 1. (B) Western blots for cell extracts in (A) were
sis was performed as in Fig. 1.
Fig. 4. Growth regulation on PGC-1β expression. (A) mRNA expression levels of PGC-1β
in cells from Fig. 1D were measured. The relative amount in 10% FBS was set as 1. (B–C)
Cells were transiently transfected with the PGC-1β-promoter luciferase reporter as in
Ref. [8]. Luciferase activity was measured as in “Materials and methods” (B) Six hours
after transfection, cells were starved in different amounts of FBS for 24 h. (C) Six hours
after transfection, cells were treated with different amounts of U0126 for 24 h.
Statistical analysis was performed as in Fig. 1.
Fig. 5. PGC-1β over-expression partially reverses the effects of U0126 onmitochondrial mass
for 24 h and then starved overnight in 0.1% FBS. Non-starved cells (10% FBS) were set at 100
24 h and then starved overnight before re-fed with 10% FBS for 12 h. Different doses of U012
Statistical analysis was performed as in Fig. 1.
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promoter region may mediate the signal derived from the MEK–ERK
cascade to govern mitochondrial biogenesis.
3.4. Over-expressing PGC-1β partially blunts the suppression of
mitochondrial mass mediated by U0126
Finally, we examined the importance of this MEK–ERK cascade-
stimulated PGC-1β expression to mitochondrial biogenesis. We ﬁrst
checked if over-expression of MEK1 or MEK2 would enhance
mitochondrial biogenesis. A549 cells were transiently transfected
with a control, MEK1, or MEK2 expression vector for 24 h before
serum starvation overnight. Over-expression of MEK1 or MEK2 was
sufﬁcient to restore the level of mitochondrial mass similar to full
serum level (Fig. 5A). Concordantly, over-expression of PGC-1β
increased the basal level of mitochondrial mass and partially reversed
the reduction in mitochondrial mass mediated by U0126 (Fig. 5B),
conﬁrming a role for PGC-1β in promoting mitochondrial biogenesis
under the inﬂuence of MEK–ERK cascade.
4. Discussion
Mitochondrial biogenesis and function are intimately linked to cell
cycle progression. Tumor suppressor Rb promotes mitochondrial
biogenesis [16]; whereas, p53 inﬂuences mitochondrial function [17].
In our current study, we provide evidences that the MEK–ERK cascade
governs mitochondrial biogenesis through selectively stimulating
PGC-1β expression; thus, priming cells for entry into rapidly growing
phase. Speciﬁcally, the expression level of PGC-1β correlated with
serum starvation and re-fed treatments. Additionally, MEK1/2
inhibitor U0126 dose-dependently reduced PGC-1β expression level.
The expression level of PGC-1β is likely under the guidance of
different transcription factors that recognizes speciﬁc response
elements on its promoter. Bioinformatics analysis of the 2 kb PGC-
1β promoter region reveals several estrogen-related receptor re-
sponse elements (ERREs) (data not shown). We indeed found that
both ERRα and ERRγ enhanced the expression of the PGC-1β-
promoter-luciferase reporter and U0126 dose-dependently sup-
pressed these enhancements (supplemental data Fig. S7). Although
the mRNA and protein levels of both ERRα and ERRγ were not
signiﬁcantly altered by U0126 treatment (Fig. 3), their transcriptional
activitiesmay nonetheless be suppressed. Of note, the activity of ERRα
is enhanced by epidermal growth factor in breast cancer cells [18].
Incidentally, knockingdownERRαbyRNAi reduces the inductionof cyt-
C in primary Schwann cells stimulated with neuregulin and insulin-like. (A) Cells were transiently transfected with a control, MEK1, or MEK2 expression vector
%. (B) Cells were transiently transfected with a control or PGC-1β expression vector for
6 were added during serum re-fed. (A and B) Relative mitochondrial mass were shown.
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communicates to these receptors through post-translational modiﬁca-
tion such as phosphorylation on the receptors themselves or their
cofactors to inﬂuence DNA binding and transcriptional activities.
The differential roles of ERRα, ERRγ, PGC-1α and PGC-1β in cancer
are just beginning to be investigated. ERRα has been suggested to be a
prognostic marker for breast, ovarian, prostate, and colon cancers
[20]. Using different ERRα inverse agonists, we and others have
shown that suppressing its activity leads to cell cycle arrest or
apoptosis in vitro and reduces tumor growth in vivo [9,21–23]. In
contrast, over-expressing ERRγ has been demonstrated to reduce
prostate cancer growth [24]. On the other hand, the roles of PGC-1α
and PGC-1β in cancer have not been fully investigated. Intriguingly,
our data suggest that PGC-1α and PGC-1β respond differentially to
growth factor signaling. Namely, only the expression of PGC-1β is
under the inﬂuence of the MEK–ERK cascade. It would be informative
to examine if the expression levels of PGC-1β are elevated in cancers
that are characterized by over-activation of receptor tyrosine kinase.
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